TF and chronic kidney disease: Our investigation looks at hemoglobin levels, ferritin level, transferrin saturation, and treatment related Treatment Emergent Adverse Events (TEAEs) incidence in chronic kidney disease patients administered ferumoxytol compared to those in patients taking conventional iron supplement formulations.